MIMS Group and Ashfield Healthcare Communications KK combine operations in Japan

October 23, 2019 - 04:29
MIMS Group and Ashfield Healthcare Communications KK combine operations in Japan

SINGAPORE - Media OutReach - 23 October 2019 - MIMSGroup, Asia's largest multi-channel provider of drug information, medical communications, eventsmanagement and marketing services, and Ashfield Healthcare Communications KK,announced they have combined operations in Japan. The newly establishedorganisation will be operating as MIMS Japan Co. Ltd.

 

MIMS and Ashfield Healthcare Communications formed astrategic alliance in January 2019. The synergy between MIMS and AshfieldHealthcare Communications will use local knowledge within country to executebest in class and compliant regional and global programs at the local level. Itwill provide clients with strengthened capabilities from both organisationsincluding Japanese and English medical communications and publications servicesfor the local Japan- market, APAC region wide scientific strategy and digitalhealthcare expertise and global solutions.

 

MIMS Group, now under the umbrella of SMS Co. Ltd. (TYO2175), has been offering diverse expertise for over 50 years in 17 countriesand markets in Asia, Oceana and the Middle East with a focus on providing marketingsupport services to pharmaceutical companies, error detection system integratedin healthcare institutions as well as services to empower healthcare professionalsin their daily operations. MIMS marketing platform services is spread across 10countries mainly in South East Asia and has over 2.5 million healthcareprofessionals registered on the mims.com website, with drug directory services,medical communications, as well as media platform business. MIMS Japan Co.Ltd., headed by CEO Yasunobu Sakai, was established in April 2017, offeringone-stop services in the Asia Pacific region to Japanese pharmaceuticalmanufacturers, healthcare and food manufacturing companies

 

"The alliance with Ashfield Healthcare Communications enablesus to give a distinct benefit of delivering a global standard quality to ourJapanese clients, in addition to the one stop services for expanding in SouthEast Asia being offered by MIMS Japan Co. Ltd. " said Yasunobu Sakai, CEO ofMIMS Group.

 

Ashfield Healthcare Communications, part of UDGHealthcare plc, provides global solutions for clients, adding value byconnecting scientific excellence, creativity and data capabilities toflawlessly execute powerful, multichannel communication solutions. AshfieldHealthcare Communications has a global network of 1,300 employees collaboratingwith more than 100 pharma, biotech, device and nutraceutical companies.

 

Ashfield Healthcare CommunicationsExecutive Director Richard Lawrence said: "Ashfield Healthcare Communicationsalready works with several Japanese pharmaceutical companies on a global basis.Further strengthening our partnership with MIMs will enhance our ability tobetter serve these companies regionally and in the Japan market."

 

Victor Wright, MIMS Chief ClientOfficer for pharma marketing said, "As the largest medical communicationscompany in the APAC region outside of Japan and China, MIMS Group has the localcountry expertise to help Japanese companies extend their programs andcommunications throughout the APAC region."

 

For more information on MIMS, visit https://corporate.mims.com or www.mimsmc.com for medical communications services.

 

For Ashfield Healthcare Communications, visit www.ashfieldhealthcare.com


NOTES TO EDITOR

About MIMS

MIMS Group, now under the umbrella of SMS Co. Ltd. (TYO2175), has been offering diverse expertise for over 50 years in 17 countriesand markets in Asia, Oceana and the Middle East with a focus on providingmarketing support services to pharmaceutical companies, error detection systemintegrated in healthcare institutions as well as services to empower healthcareprofessionals in their daily operations. MIMS marketing platform services isspread across 10 countries mainly in South East Asia and has over 2.5 millionhealthcare professionals registered on the mims.com website, with drug directoryservices, medical communications, as well as media platform business. MIMSJapan Co. Ltd., headed by CEO Yasunobu Sakai, was established in April 2017,offering one-stop services in the Asia Pacific region to Japanesepharmaceutical manufacturers, healthcare and food manufacturing companies


MIMS has offices in the following countries & regions:


Singapore (headquarters), Australia, China, Hong Kong SAR(China), Indonesia, India, Ireland, Japan, Korea, Malaysia, Myanmar, NewZealand, Philippines, Taiwan, Thailand, UAE, and Vietnam.


Visit https://corporate.mims.com to learn more, and www.mimsmc.com for medical communications services.


About Ashfield Healthcare Communications

Ashfield Healthcare Communications, part of UDGHealthcare plc, provides global solutions for clients, adding value throughunique insights and tailored scientifically rigorous, multichannel, healthcarecommunications offerings. Its mission is to improve lives by helping healthcareprofessionals and patients get the medicines, knowledge, and support they need.Ashfield Healthcare Communications' multichannel and specialist agenciesinclude ACUMED, Ashfield Digital & Creative, Ashfield HealthcareCommunications K.K., BlueMomentum, Cambridge BioMarketing, CircleScience,Cirrus Communications, Clinical Bridges, CodonMedical, Create NYC, FireKite,Galliard, Gardiner-Caldwell Communications, GeoMed, iMed Comms, Infusion,MicroMass, Nyxeon, Pegasus, Physicians World Europe, QXV Comms, ScientificConnexions, Seren Communications, StemScientific, Watermeadow Medical, andZoetic Science.

For more information, please go to www.ashfieldhealthcarecommunications.com.


About Ashfield

Ashfield, part of UDG Healthcare plc, is a global leaderin commercialisation services for the healthcare industry. We partner with ourclients across Advisory, Healthcare Communications, Commercial, PatientSolutions and Medical Affairs to build creative, scalable and tailored healthsolutions that are executed flawlessly, to deliver positive outcomes forpatients and add value to your business. With 7,000 employees, the companyoperates in 25 countries, delivering services in more than 50 countries acrossEurope, North America, South America and Asia. It works with more than 250businesses, including all of the world's top 25 pharmaceutical companies.


Its mission is to partner with itsclients, helping to improve lives by ensuring healthcare professionals andpatients get the medicines, knowledge and support they need.


Ashfield provides contract salesteams, customer service reps, medical science liaison officers, remotedetailing, nurse educators, medical information, healthcare communications,market access, market research, training, live and virtual events, digital,creative, pharmacovigilance, audit and advisory services.


For more information, go to www.ashfieldhealthcare.com.

E-paper